U.S. Department of Health and Human Services

CRS 2024 (v24.0 and v24.1)

CRS VERSION 24.1

CRS Version 24.1 was released on August 27, 2024.

View the CRS 2024 (v24.1) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 695 KB]
View the CRS 2024 (v24.1) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 801 KB]

Key enhancements included in CRS Version 24.1 are shown below.

Logic Changes to National GPRA/GPRAMA Report Measures
- GPRA Developmental Measures:
  - Added the following GPRA Developmental topics:
    - Colorectal Cancer Screening (ages updated to 40-75)
    - Screening for Substance Use (added measures for alcohol and drug use risk screen)
  - Updated codes and/or logic in the following measures: Access to Dental Service; Caries Risk Assessment; Adolescent Immunizations; Cancer Screening: Mammogram Rates; Screening for Substance Use; Substance Use Disorder (SUD) in Women of Childbearing Age; Suicide Risk Assessment; Weight Assessment and Counseling for Nutrition and Physical Activity; HIV Screening; HIV Quality of Care; Hepatitis C Screening; Chlamydia Testing; Proportion of Days Covered by Medication Therapy; Concurrent Use of Opioids and Benzodiazepines.
- Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes: (1) Removed measure with Active Diabetic Denominator. (2) Updated age range for patients with LDL-C greater than or equal to (≥) 190 mg/dL or diagnosis of familial hypercholesterolemia to 20 through 75. (3) Added patients ages 40 through 75 with a 10-year ASCVD risk score of greater than or equal to (≥) 20% to the denominator.
- Diabetic Retinopathy: (1) Added HCPCS M1220, M1221 to Diabetic Retinal Exam definition. (2) Added LOINC code 103616-9 to BGP CREATININE LOINC CODES.
- Cervical Cancer Screening: (1) Added CPT 0429U to HPV DNA definition. (2) Added LOINC codes 104170-6, 104132-6 to BGP HPV LOINC CODES. (3) Added LOINC code 104132-6 to BGP HPV PRIMARY LOINC CODES.
- Cancer Screening: Mammogram Rates: Added HCPCS M1280 to bilateral mastectomy definition.
- Colorectal Cancer Screening: Added HCPCS M1295 to total colectomy definition.
- Alcohol Screening: Added CAGE-AID and TAPS-Alcohol Health Factors to alcohol screening and positive screen definitions.
- Screening, Brief Intervention, and Referral to Treatment (SBIRT): Added CAGE-AID and TAPS-Alcohol Health Factors to alcohol screening and positive screen definitions.
- Depression Screening: (1) Removed PHQ2 from depression screening definition. (2) Added Edinburgh Postnatal Depression Scale (EPDS) to depression screening definition.
- Statin Therapy for the Prevention and Treatment of Cardiovascular Disease: (1) Removed measure with Active Diabetic Denominator. (2) Updated age range for patients with LDL-C greater than or equal to (≥) 190 mg/dL or diagnosis of familial hypercholesterolemia to 20 through 75. (3) Added patients ages 40 through 75 with a 10-year ASCVD risk score of greater than or equal to (≥) 20% to the denominator.

CRS VERSION 24.0

CRS Version 24.0 was released on February 26, 2024.

View the CRS 2024 (v24.0) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 682 KB]
View the CRS 2024 (v24.0) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 782 KB]

Key enhancements included in CRS Version 24.0 are shown below.

Logic Changes to National GPRA/GPRAMA Report Measures
- GPRA Developmental Measures:
  - Added the following GPRA Developmental topics:
    - Influenza (updated time period to align with flu season)
    - Cancer Screening: Mammogram Rates (ages updated to 42-74)
  - Updated codes and/or logic in the following measures: Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes; Access to Dental Service; Dental Sealants; Topical Fluoride; Caries Risk Assessment; Adult Immunizations; Childhood Immunizations; Appropriate Medication Therapy after a Heart Attack; HIV Screening; HIV Quality of Care; Chlamydia Testing; Sexually Transmitted Infection (STI) Screening; Proportion of Days Covered by Medication Therapy; Concurrent Use of Opioids and Benzodiazepines.
- Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes: (1) Updated BGP PQA STATIN MEDS medication taxonomy. (2) Added POV ICD-10: Z51.5 to Palliative Care Definition.
- Access to Dental Service: Added D to prefix of RPMS/ADA CDT Dental Codes.
- Dental Sealants: Added D to prefix of RPMS/ADA CDT Dental Codes.
- Topical Fluoride: Added D to prefix of RPMS/ADA CDT Dental Codes.
- Influenza: Added CVX codes 123, 125-128, 160, 231 and CPT codes 90663, 90664, 90666, 90668 to Influenza definition.
- Adult Immunizations: Added CVX codes 123, 125-128, 160, 231 and CPT codes 90663, 90664, 90666, 90668 to Influenza definition.
- Childhood Immunizations: (1) Added CVX codes 215, 216 and CPT codes 90671, 90677 to Pneumococcal definition. (2) Removed POV 795.71 (Nonspecific serologic evidence of HIV) from HIV definition.
- Tobacco Use and Exposure Assessment: Added D to prefix of RPMS/ADA CDT Dental Codes.
- Tobacco Cessation: (1) Added D to prefix of RPMS/ADA CDT Dental Codes. (2) Changed Medication Taxonomy from BGP CMS Smoking cessation to BGP ECQM TOB CESSATION MEDS.
- Statin Therapy for the Prevention and Treatment of Cardiovascular Disease: (1) Updated BGP PQA STATIN MEDS medication taxonomy. (2) Added POV ICD-10: Z51.5 to Palliative Care Definition.
- HIV Screening: Removed POV 795.71 (Nonspecific serologic evidence of HIV) from HIV definition.

CRS 2024 Documentation